Valuation: NeuroPace, Inc.

Market Cap 482M 412M 386M 353M 664M 46.08B 672M 4.56B 1.78B 23.14B 1.81B 1.77B 76.54B P/E 2026 *
-27.8x
P/E 2027 * -52x
Enterprise Value 505M 432M 404M 370M 696M 48.3B 704M 4.78B 1.86B 24.26B 1.9B 1.85B 80.23B EV / Sales 2026 *
5.04x
EV / Sales 2027 * 4.06x
Free-Float
83.08%
Yield 2026 *
-
Yield 2027 * -
1 day+0.07%
1 week-5.01%
Current month+8.84%
1 month-3.77%
3 months-17.08%
6 months-2.16%
Current year-9.13%
1 week 13.56
Extreme 13.56
15.28
1 month 12.66
Extreme 12.66
15.83
Current year 12.47
Extreme 12.47
19.6
1 year 8.61
Extreme 8.61
19.6
3 years 4.79
Extreme 4.79
19.6
5 years 1.22
Extreme 1.22
24.65
10 years 1.22
Extreme 1.22
27.38
Manager TitleAgeSince
Chief Executive Officer 58 2023-07-09
Director of Finance/CFO 53 2025-06-19
Chief Tech/Sci/R&D Officer - 2024-09-03
Director TitleAgeSince
Director/Board Member 57 2012-12-31
Chairman 84 1997-11-30
Director/Board Member 46 2021-03-31
Date Insider Type Main position Quantity % Market Cap.
6/19/26 Free

Director

789 0.0023%
5/15/26 Free

Chief Financial Officer

61,620 0.1815%
2/27/26 Tax

Chief Executive Officer

1,126 0.0034%
Change 5-day change 1-year change 3-year change Capi.($)
+0.07%-5.01%+56.06%+212.47% 482M
+0.27%+6.97%+25.86%+19.39% 233B
+1.36%+8.10%+3.33%-12.35% 154B
+1.16%-3.98%-20.44%+31.92% 134B
+2.03%-2.82%-52.56%-0.08% 73B
+0.98%+2.26%-16.22%-12.49% 52.24B
-0.04%-1.98%+9.73%+18.19% 51.75B
+1.73%+7.05%+30.72%+35.16% 44.91B
+1.49%-0.36%+35.91%+53.26% 40.35B
+1.03%+1.53%-0.53%+8.54% 33.8B
Average +1.01%+1.08%+7.19%+35.40% 81.69B
Weighted average by Cap. +0.98%+2.99%+3.00%+13.82%

Financials

2026 *2027 *
Net sales 100M 85.83M 80.3M 73.46M 138M 9.59B 140M 950M 370M 4.82B 376M 368M 15.93B 123M 105M 98.31M 89.93M 169M 11.74B 171M 1.16B 453M 5.9B 461M 451M 19.5B
Net income -17.35M -14.86M -13.9M -12.72M -23.92M -1.66B -24.2M -164M -64M -834M -65.14M -63.72M -2.76B -9.63M -8.25M -7.72M -7.06M -13.29M -922M -13.44M -91.3M -35.54M -463M -36.17M -35.38M -1.53B
Net Debt 23.21M 19.88M 18.6M 17.01M 32.01M 2.22B 32.38M 220M 85.63M 1.12B 87.15M 85.25M 3.69B 16.02M 13.72M 12.83M 11.74M 22.09M 1.53B 22.35M 152M 59.09M 770M 60.14M 58.83M 2.55B
Logo NeuroPace, Inc.
NeuroPace, Inc. is a medical device company focused on transforming the lives of people living with epilepsy by reducing or eliminating the occurrence of debilitating seizures. The Company's RNS System is a brain-responsive platform that delivers personalized, real-time treatment at the seizure source. This platform can drive a better standard of care for patients living with drug-resistant epilepsy and has the potential to offer a more personalized solution and improved outcomes to the large population of patients suffering from other brain disorders. The Company's RNS System includes its RNS neurostimulator, its cortical strip leads and depth leads, and its Patient Remote Monitor, as well as other implantable and non-implantable accessories. The Company's product offerings also include Physician Tablet, Patient Data Management System (PDMS) and nSight Platform, which facilitate ongoing patient monitoring and streamline patient support. The PDMS is an online database.
Employees
220
Date Price Change Volume
26-08-21 US$14.03 +0.07% 115,977
26-08-20 US$14.02 -4.23% 191,795
26-08-19 US$14.64 +1.17% 106,610
26-08-18 US$14.47 +1.33% 140,668
26-08-17 US$14.28 -3.32% 197,436
Trader
Investor
-
Global
-
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
9
Last Close Price
14.03USD
Average target price
20.22USD
Spread / Average Target
+44.14%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. NPCE Stock